These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23745766)

  • 1. Association between the XRCC6 Promoter rs2267437 polymorphism and cancer risk: evidence based on the current literature.
    Xu H; Zou P; Chen P; Zhao L; Zhao P; Lu A
    Genet Test Mol Biomarkers; 2013 Aug; 17(8):607-14. PubMed ID: 23745766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk.
    Jiang H; Lin Y; Yang CQ; Li Q; Luo J; Zhou Y; Xue J; Wei W; Gao Y
    Tumour Biol; 2013 Apr; 34(2):779-85. PubMed ID: 23271361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the genetic polymorphisms in XRCC6 and XRCC5 with the risk of ESCC in a high-incidence region of North China.
    Li K; Yin X; Yang H; Yang J; Zhao J; Xu C; Xu H
    Tumori; 2015; 101(1):24-9. PubMed ID: 25702660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XRCC5/6 polymorphisms and their interactions with smoking, alcohol consumption, and sleep satisfaction in breast cancer risk: A Chinese multi-center study.
    Yu LX; Liu LY; Xiang YJ; Wang F; Zhou F; Huang SY; Zheng C; Ye CM; Zhou WZ; Yin GS; Zhang JL; Cui SD; Tian FG; Fan ZM; Geng CZ; Cao XC; Yang ZL; Wang X; Liang H; Wang S; Jiang HC; Duan XN; Wang HB; Li GL; Wang QT; Zhang JG; Jin F; Tang JH; Li L; Zhu SG; Zuo WS; Ma ZB; Yu ZG
    Cancer Med; 2021 Apr; 10(8):2752-2762. PubMed ID: 33734613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the Ku70-1310C/G promoter polymorphism and cancer risk: a meta-analysis.
    Xu L; Ju XB; Li P; Wang J; Shi ZM; Zheng MJ; Xue DD; Xu YJ; Yin YM; Wang S; You YP
    Asian Pac J Cancer Prev; 2012; 13(2):683-7. PubMed ID: 22524845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional polymorphism C-1310G in the promoter region of Ku70/XRCC6 is associated with risk of renal cell carcinoma.
    Wang W; Pan X; Huo X; Yan F; Wang M; Wang D; Gao Y; Cao Q; Luo D; Qin C; Yin C; Zhang Z
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E183-90. PubMed ID: 22593040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ku70 -1310C/G promoter polymorphism is associated with breast cancer susceptibility in Chinese Han population.
    He W; Luo S; Huang T; Ren J; Wu X; Shao J; Zhu Q
    Mol Biol Rep; 2012 Jan; 39(1):577-83. PubMed ID: 21556760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the XRCC6 polymorphisms and cancer risks: a systematic review and meta-analysis.
    Jia J; Ren J; Yan D; Xiao L; Sun R
    Medicine (Baltimore); 2015 Jan; 94(1):e283. PubMed ID: 25569644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of XRCC6 T-991C functional polymorphism in renal cell carcinoma.
    Chang WS; Ke HL; Tsai CW; Lien CS; Liao WL; Lin HH; Lee MH; Wu HC; Chang CH; Chen CC; Lee HZ; Bau DT
    Anticancer Res; 2012 Sep; 32(9):3855-60. PubMed ID: 22993329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between XRCC5, 6 and 7 gene polymorphisms and the risk of breast cancer: a HuGE review and meta-analysis.
    Zhou LP; Luan H; Dong XH; Jin GJ; Man DL; Shang H
    Asian Pac J Cancer Prev; 2012; 13(8):3637-43. PubMed ID: 23098447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of XRCC6/Ku70 to hepatocellular carcinoma in Taiwan.
    Hsu CM; Yang MD; Chang WS; Jeng LB; Lee MH; Lu MC; Chang SC; Tsai CW; Tsai Y; Tsai FJ; Bau DT
    Anticancer Res; 2013 Feb; 33(2):529-35. PubMed ID: 23393345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of XRCC6/Ku70 in nasopharyngeal carcinoma.
    Huang CY; Tsai CW; Hsu CM; Shih LC; Chang WS; Shui HA; Bau DT
    Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1480-5. PubMed ID: 26149939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of DNA double-strand break gene XRCC6 genotypes and lung cancer in Taiwan.
    Hsia TC; Liu CJ; Chu CC; Hang LW; Chang WS; Tsai CW; Wu CI; Lien CS; Liao WL; Ho CY; Bau DT
    Anticancer Res; 2012 Mar; 32(3):1015-20. PubMed ID: 22399625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.
    Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Rodríguez-Melcón JI; Herrera-Ramos E; Rodríguez-Gallego C; Lara PC
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):28-34. PubMed ID: 26754263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of DNA double strand break gene Ku70 and gastric cancer in Taiwan.
    Yang MD; Wang HC; Chang WS; Tsai CW; Bau DT
    BMC Cancer; 2011 May; 11():174. PubMed ID: 21575261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms in DNA double-strand break repair genes XRCC5, XRCC6 and susceptibility to hepatocellular carcinoma.
    Li R; Yang Y; An Y; Zhou Y; Liu Y; Yu Q; Lu D; Wang H; Jin L; Zhou W; Qian J; Shugart YY
    Carcinogenesis; 2011 Apr; 32(4):530-6. PubMed ID: 21304054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between rs20417 polymorphism in cyclooxygenase-2 and gastric cancer susceptibility: Evidence from15 case-control studies.
    Chen S; Chen L; Tan Y; Wang J
    Medicine (Baltimore); 2019 May; 98(18):e15468. PubMed ID: 31045826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between polymorphisms at promoters of XRCC5 and XRCC6 genes and risk of breast cancer.
    Rajaei M; Saadat I; Omidvari S; Saadat M
    Med Oncol; 2014 Apr; 31(4):885. PubMed ID: 24615008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the rs4784227-CASC16 polymorphism and the risk of breast cancer: A meta-analysis.
    Xu W; Zhong Y; Yang H; Gong Y; Dao J; Bao L
    Medicine (Baltimore); 2022 Aug; 101(34):e30218. PubMed ID: 36042591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of hOGG1 Ser326Cys polymorphism with susceptibility to hepatocellular carcinoma.
    Guo J; Yang J; Li Y
    Int J Clin Exp Med; 2015; 8(6):8977-85. PubMed ID: 26309550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.